[Therapeutic experiences in multiple myeloma].
D000814:Aniline Compounds / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001799:Blood Sedimentation; D002330:Carmustine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D006452:Hemoglobinometry; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy*; D009150:Mustard Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous
D000814:Aniline Compounds; D000970:Antineoplastic Agents; D009150:Mustard Compounds; D011344:Procarbazine; D008558:Melphalan; D002330:Carmustine; D011241:Prednisone
Therapeutische Erfahrungen beim multiplen Myelom.